600488 津药药业
已收盘 09-17 15:00:00
资讯
新帖
简况
津药药业：目前产品管线中未涉及用于治疗梅毒的抗生素产品
证券之星 · 09-16 15:54
津药药业：目前产品管线中未涉及用于治疗梅毒的抗生素产品
津药药业：截至2026年9月10日，公司股东数为79,012户
证券之星 · 09-14 15:51
津药药业：截至2026年9月10日，公司股东数为79,012户
津药药业(600488.SH)子公司盐酸布比卡因注射液获药品注册证书
智通财经 · 09-14
津药药业(600488.SH)子公司盐酸布比卡因注射液获药品注册证书
每周股票复盘：津药药业（600488）因股价涨幅偏离上榜龙虎榜
证券之星 · 09-13
每周股票复盘：津药药业（600488）因股价涨幅偏离上榜龙虎榜
津药药业（600488）披露董事会换届选举公告，9月9日股价上涨0.94%
证券之星 · 09-09
津药药业（600488）披露董事会换届选举公告，9月9日股价上涨0.94%
每周股票复盘：津药药业（600488）参与投资者网上集体接待日活动
证券之星 · 09-06
每周股票复盘：津药药业（600488）参与投资者网上集体接待日活动
股市必读：津药药业新发布《津药药业股份有限公司关于参加2026年天津辖区上市公司投资者网上集体接待日活动情况公告》
证券之星 · 09-04
股市必读：津药药业新发布《津药药业股份有限公司关于参加2026年天津辖区上市公司投资者网上集体接待日活动情况公告》
股市必读：津药药业（600488）9月1日董秘有最新回复
证券之星 · 09-02
股市必读：津药药业（600488）9月1日董秘有最新回复
津药药业：截至2026年8月31日，公司股东数为82,649户
证券之星 · 09-01
津药药业：截至2026年8月31日，公司股东数为82,649户
每周股票复盘：津药药业（600488）股东户数增29.63%，扣非净利降63.24%
证券之星 · 08-30
每周股票复盘：津药药业（600488）股东户数增29.63%，扣非净利降63.24%
津药药业（600488）2026年中报简析：净利润同比下降12.43%
证券之星 · 08-27
津药药业（600488）2026年中报简析：净利润同比下降12.43%
图解津药药业中报：第二季度单季净利润同比增长434.81%
证券之星 · 08-26
图解津药药业中报：第二季度单季净利润同比增长434.81%
津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%
证券之星 · 08-25
津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%
股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元
证券之星 · 08-25
股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元
股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》
证券之星 · 08-19
股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》
津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书
智通财经 · 08-17
津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书
股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》
证券之星 · 08-17
股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》
津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价
智通财经 · 08-14
津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价
津药药业：甾体激素原料药价格总体保持平稳
证券之星 · 08-12
津药药业：甾体激素原料药价格总体保持平稳
津药药业：截至2026年8月10日，公司股东数为110,517户
证券之星 · 08-11
津药药业：截至2026年8月10日，公司股东数为110,517户
加载更多
公司概况
公司名称：
津药药业股份有限公司
所属行业：
医药制造业
上市日期：
2001-06-18
主营业务：
津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类、制剂。
发行价格：
11.25
{"stockData":{"symbol":"600488","market":"SH","secType":"STK","nameCN":"津药药业","latestPrice":5.99,"timestamp":1789628400000,"preClose":6.02,"halted":0,"volume":137681050,"delay":0,"changeRate":-0.005,"floatShares":1092000000,"shares":1092000000,"eps":0.0591,"marketStatus":"已收盘","change":-0.03,"latestTime":"09-17 15:00:00","open":5.99,"high":6.27,"low":5.9,"amount":835000000,"amplitude":0.0615,"askPrice":6,"askSize":1235,"bidPrice":5.99,"bidSize":4037,"shortable":0,"etf":0,"ttmEps":0.0591,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":5,"adr":0,"adjPreClose":6.02,"symbolType":"stock","openAndCloseTimeList":[[1789608600000,1789615800000],[1789621200000,1789628400000]],"highLimit":6.62,"lowLimit":5.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1091886680,"isCdr":false,"pbRate":2.16,"roa":"--","peRate":101.353638,"roe":"1.41%","epsLYR":0.065,"committee":0.576113,"marketValue":6540000000,"turnoverRate":0.1261,"status":1,"floatMarketCap":6540000000},"requestUrl":"/m/hq/s/600488","defaultTab":"news","newsList":[{"id":"2667605936","title":"津药药业：目前产品管线中未涉及用于治疗梅毒的抗生素产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667605936?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:54","pubTimestamp":1789545257,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！贵公司是否有梅毒抗生素？谢谢津药药业回复：投资者您好！公司主营业务为甾体激素类、氨基酸类原料药及制剂的研发、生产和销售，目前产品管线中未涉及用于治疗梅毒的抗生素产品。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600021867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600488","BK0012","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965699","title":"津药药业：截至2026年9月10日，公司股东数为79,012户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667965699?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:51","pubTimestamp":1789372285,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止9月10日最新股东数？津药药业回复：投资者您好！截至2026年9月10日，公司股东数为79,012户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400016563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0102","BK0028","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655230","title":"津药药业(600488.SH)子公司盐酸布比卡因注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655230","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667655230?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:36","pubTimestamp":1789371366,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司湖北津药药业股份有限公司收到国家药品监督管理局核准签发的盐酸布比卡因注射液的《药品注册证书》。盐酸布比卡因注射液用于局部浸润麻醉、外周神经阻滞和椎管内阻滞。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"津药药业(600488.SH)子公司盐酸布比卡因注射液获药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0102","BK0012","600488","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667502235","title":"每周股票复盘：津药药业（600488）因股价涨幅偏离上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2667502235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667502235?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:08","pubTimestamp":1789232895,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，津药药业报收于5.35元，较上周的5.15元上涨3.88%。本周，津药药业9月10日盘中最高价报5.9元。津药药业当前最新总市值58.42亿元，在化学制药板块市值排名81/149，在两市A股市值排名2782/5218。本周关注点来自交易信息汇总：津药药业因日收盘价格涨幅偏离值达7%登上龙虎榜。来自公司公告汇总：津药药业启动第十届董事会换届，提名9名董事候选人。此次是近5个交易日内第1次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","600488","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666897405","title":"津药药业（600488）披露董事会换届选举公告，9月9日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666897405","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666897405?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:26","pubTimestamp":1788945983,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，津药药业报收于5.36元，较前一交易日上涨0.94%，最新总市值为58.53亿元。近日，津药药业股份有限公司发布《2026年第二次临时股东会会议资料》公告。公告显示，公司第九届董事会任期届满，根据《公司法》和《公司章程》规定，将进行董事会换届选举。第十届董事会由9名董事组成，其中非独立董事5名，独立董事3名，任期三年。职工代表董事将由职工大会选举产生。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0012","BK0102","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665654143","title":"每周股票复盘：津药药业（600488）参与投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2665654143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665654143?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:16","pubTimestamp":1788632172,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，津药药业报收于5.15元，较上周的5.6元下跌8.04%。本周，津药药业8月31日盘中最高价报5.55元。9月4日盘中最低价报5.11元。津药药业当前最新总市值56.23亿元，在化学制药板块市值排名85/149，在两市A股市值排名2914/5214。本周关注点公司公告汇总：津药药业于2026年9月3日参加天津辖区上市公司投资者网上集体接待日活动，就市场开拓、研发项目及发展战略与投资者交流。相关信息以公司公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","600488","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882806","title":"股市必读：津药药业新发布《津药药业股份有限公司关于参加2026年天津辖区上市公司投资者网上集体接待日活动情况公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882806","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664882806?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:40","pubTimestamp":1788457225,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，津药药业报收于5.23元，下跌1.69%，换手率2.85%，成交量31.13万手，成交额1.63亿元。公司公告汇总：津药药业于9月3日参加天津辖区上市公司投资者网上集体接待日，就市场开拓、研发项目及发展战略等与投资者交流，并回应二氟泼尼酯滴眼液布局、原料药制剂一体化、集采应对等具体问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600488","BK0028","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863999","title":"股市必读：津药药业（600488）9月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863999?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:37","pubTimestamp":1788284229,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，津药药业报收于5.43元，上涨2.07%，换手率5.17%，成交量56.45万手，成交额3.05亿元。董秘最新回复投资者： 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月31日A股股东人数是多少？祝公司业绩越来越好，股价节节攀升。截至2026年8月31日，公司股东数为82,649户。当日关注点交易信息汇总：9月1日主力资金净流入912.41万元，占总成交额2.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600488","BK0102","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664376834","title":"津药药业：截至2026年8月31日，公司股东数为82,649户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664376834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664376834?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:12","pubTimestamp":1788250327,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月31日A股股东人数是多少？祝公司业绩越来越好，股价节节攀升。谢谢津药药业回复：投资者您好！截至2026年8月31日，公司股东数为82,649户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100026512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0239","BK0102","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663106400","title":"每周股票复盘：津药药业（600488）股东户数增29.63%，扣非净利降63.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663106400","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663106400?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:37","pubTimestamp":1788028629,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，津药药业报收于5.6元，较上周的5.51元上涨1.63%。股本股东变化截至2026年8月10日，津药药业股东户数为11.05万户，较7月31日增加2.53万户，增幅达29.63%。业绩披露要点津药药业2026年中报显示，上半年主营收入13.13亿元，同比下降17.33%；归母净利润4317.35万元，同比下降12.43%；扣非净利润4286.81万元，同比下降63.24%。第二季度单季主营收入7.05亿元，同比下降12.17%；单季归母净利润2928.22万元，同比上升434.81%；单季扣非净利润2890.06万元，同比下降51.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","600488","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662989740","title":"津药药业（600488）2026年中报简析：净利润同比下降12.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662989740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662989740?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:04","pubTimestamp":1787781898,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期津药药业发布2026年中报。根据财报显示，津药药业净利润同比下降12.43%。截至本报告期末，公司营业总收入13.13亿元，同比下降17.33%，归母净利润4317.35万元，同比下降12.43%。按单季度数据看，第二季度营业总收入7.05亿元，同比下降12.17%，第二季度归母净利润2928.22万元，同比上升434.81%。去年的净利率为4.2%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759164","title":"图解津药药业中报：第二季度单季净利润同比增长434.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759164","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662759164?lang=zh_cn&edition=full","pubTime":"2026-08-26 01:38","pubTimestamp":1787679498,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业2026年中报显示，上半年度公司主营收入13.13亿元，同比下降17.33%；归母净利润4317.35万元，同比下降12.43%；扣非净利润4286.81万元，同比下降63.24%；其中2026年第二季度，公司单季度主营收入7.05亿元，同比下降12.17%；单季度归母净利润2928.22万元，同比上升434.81%；单季度扣非净利润2890.06万元，同比下降51.24%；负债率33.13%，投资收益-8.65万元，财务费用1611.49万元，毛利率41.47%。财报数据概要请见下图:本文数据来源于津药药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600004215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758772","title":"津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758772","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758772?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:20","pubTimestamp":1787667651,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，津药药业报收于5.45元，较前一交易日上涨5.42%，最新总市值为59.51亿元。该股当日开盘5.16元，最高5.55元，最低5.07元，成交额达3.77亿元，换手率为6.47%。近日，津药药业股份有限公司披露《2026年半年度报告》。公告显示，公司总资产为5,749,485,621.65元，较上年度末减少0.18%；归属于上市公司股东的净资产为3,023,768,744.19元，较上年度末减少0.35%。经营活动产生的现金流量净额为191,778,302.86元，同比上升849.37%。公司董事会审议通过本报告，未提出利润分配预案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","600488","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208680","title":"股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662208680?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:05","pubTimestamp":1787591114,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，津药药业报收于5.17元，下跌6.17%，换手率5.33%，成交量58.23万手，成交额3.06亿元。交易信息汇总股价提醒8月24日津药药业收盘报5.17元，跌6.17%，当日成交3.06亿元。资金流向8月24日主力资金净流出1467.34万元，占总成交额4.8%；游资资金净流出2326.0万元，占总成交额7.6%；散户资金净流入3793.34万元，占总成交额12.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500002877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0028","BK0102","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660499327","title":"股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660499327","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660499327?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:01","pubTimestamp":1787072475,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，津药药业报收于6.15元，上涨2.16%，换手率7.96%，成交量86.91万手，成交额5.29亿元。当日关注点交易信息汇总：8月18日主力资金净流入2659.22万元，占总成交额5.03%。该药品为肠外营养类处方药，适用于小儿消化系统疾病无法进食、低蛋白血症等情况。2023年提交注册申请，近期获批。2024年和2025年该药品在国内销售额分别为2.06亿元和1.46亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0028","BK0012","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488664","title":"津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488664","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660488664?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:44","pubTimestamp":1786952660,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司津药和平(天津)制药有限公司(以下简称“津药和平”)小儿复方氨基酸注射液(18AA-I)收到缅甸卫生部药品注册证书(标志着可以生产并在缅甸市场销售该产品)。本次产品顺利取得境外上市资质，为公司制剂板块海外市场开拓筑牢根基、开辟新业务增长空间，更将有力助推国际化发展战略稳步落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","600488","BK0102","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660708241","title":"股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660708241","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660708241?lang=zh_cn&edition=full","pubTime":"2026-08-17 01:21","pubTimestamp":1786900868,"startTime":"0","endTime":"0","summary":"公司公告汇总：津药药业子公司维生素B注射液新增1ml：0.1g规格，并通过仿制药一致性评价，2025年国内销售额3.72亿元。公司公告汇总津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告津药药业子公司湖北津药药业收到国家药品监督管理局核准签发的维生素B注射液《药品补充申请批准通知书》，批准新增1ml：0.1g规格，并通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0028","600488","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659277119","title":"津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659277119","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659277119?lang=zh_cn&edition=full","pubTime":"2026-08-14 15:49","pubTimestamp":1786693743,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司湖北津药药业股份有限公司收到国家药品监督管理局核准签发的维生素B₆注射液的《药品补充申请批准通知书》，批准本品新增1ml：0.1g规格及通过仿制药质量和疗效一致性评价(简称“一致性评价”)。该药品适用于维生素B₆缺乏的预防和治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","BK0028","BK0239","BK0012","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927804","title":"津药药业：甾体激素原料药价格总体保持平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658927804?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:57","pubTimestamp":1786521427,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业08月12日在投资者关系平台上答复投资者关心的问题。二季度以及最近两个月，该涨价后自产原料药的新增询价、新签订单落地情况能否介绍.若具体订单数据属于商业机密不便披露，请提示后期关注后续定期报告，感谢津药药业回复：投资者您好！目前，公司生产经营情况正常，甾体激素原料药价格总体保持平稳。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200024272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600488","BK0102","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996898","title":"津药药业：截至2026年8月10日，公司股东数为110,517户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996898?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:15","pubTimestamp":1786439725,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年8月10日，贵司最新股东总户数是多少？感谢回单津药药业回复：投资者您好！截至2026年8月10日，公司股东数为110,517户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600488","BK0102","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789630578816,"stockEarnings":[{"period":"1week","weight":0.1231},{"period":"1month","weight":0},{"period":"3month","weight":0.3345},{"period":"6month","weight":0.5179},{"period":"1year","weight":0.4088},{"period":"ytd","weight":0.4846}],"compareEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0229},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0165},{"period":"1year","weight":0.0077},{"period":"ytd","weight":-0.0195}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"津药药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"79012人(较上一季度减少4.40%)","perCapita":"13819股","listingDate":"2001-06-18","address":"天津市东丽区开发区西区新业九街19号","registeredCapital":"109188万元","survey":" 津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类、制剂。","listedPrice":11.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"津药药业,600488,津药药业股票,津药药业股票老虎,津药药业股票老虎国际,津药药业行情,津药药业股票行情,津药药业股价,津药药业股市,津药药业股票价格,津药药业股票交易,津药药业股票购买,津药药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}